AQR Arbitrage LLC - BIOPLUS ACQUISITION CORP ownership

BIOPLUS ACQUISITION CORP's ticker is and the CUSIP is G11217117. A total of 66 filers reported holding BIOPLUS ACQUISITION CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
AQR Arbitrage LLC ownership history of BIOPLUS ACQUISITION CORP
ValueSharesWeighting
Q3 2023$5,230,814
+1.7%
482,9930.0%0.24%
+5.9%
Q2 2023$5,143,875
-17.2%
482,993
-18.8%
0.22%
+16.8%
Q1 2023$6,209,274
-3.2%
594,758
-4.7%
0.19%
+15.2%
Q4 2022$6,414,247
+2.6%
623,9540.0%0.16%
+19.6%
Q3 2022$6,252,000
-0.3%
623,9540.0%0.14%
-2.1%
Q2 2022$6,271,000
+1.7%
623,9540.0%0.14%
-12.4%
Q1 2022$6,165,000623,9540.16%
Other shareholders
BIOPLUS ACQUISITION CORP shareholders Q2 2022
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 66,607$6851.08%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 1,482,836$15,2440.42%
MMCAP International Inc. SPC 400,000$4,088,0000.42%
CANTOR FITZGERALD, L. P. 1,422,204$14,5570.31%
KIM, LLC 500,000$5,1400.28%
Spartan Fund Management Inc. 74,485$7630.28%
Saba Capital Management, L.P. 1,791,845$18,384,3300.25%
Atalaya Capital Management LP 125,000$1,285,0000.23%
Radcliffe Capital Management, L.P. 555,355$5,697,9420.18%
Exos TFP Holdings LLC 62,500$638,7500.18%
View complete list of BIOPLUS ACQUISITION CORP shareholders